Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells
Lentiviral vectors (LVs) provide unique opportunities for the development of immunotherapeutic strategies, as they transduce a variety of cells in situ, including antigen-presenting cells (APCs). Engineering LVs to specifically transduce APCs is required to promote their translation towards the clin...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520013/ |